Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Can AI predict diseases before they develop?

Researchers have launched a major collaboration between Insilico Medicine and Human Longevity to develop an advanced artificial intelligence (AI) system aimed at predicting diseases long before they manifest. This partnership seeks to shift the focus of longevity science from merely treating illnesses to identifying early signs of biological decline, potentially enabling doctors to spot risks for serious conditions like cancer and heart disease years or even decades earlier than current methods allow.

This development is significant for anyone interested in aging well. By detecting health risks earlier, people could take proactive steps to maintain their muscle strength, cardiovascular health, and overall vitality. The goal is to extend not just lifespan but healthy years, reducing the burden of chronic diseases that often accompany aging. As the global population ages and healthcare costs rise, this approach could transform how we manage health and longevity, making it more about prevention rather than reaction.

The collaboration combines Insilico’s expertise in AI and drug discovery with Human Longevity’s extensive biological and clinical data. This includes genomics and long-term health records from thousands of individuals. However, while the ambition is high, the research is still in its early stages. The AI model is being developed to recognize subtle patterns in aging and disease progression, but it has yet to be proven in large human trials. The field of longevity science has faced skepticism due to past failures, but this partnership represents a shift toward more evidence-based approaches focused on early detection and preventive care.

For now, individuals interested in longevity should stay informed about advancements in preventive health and consider regular check-ups that focus on early detection of potential health issues. Engaging in healthy lifestyle choices, such as balanced nutrition and regular physical activity, remains crucial while these new technologies are being developed.

Source: longevity.technology